On September 1, 2026, Profusa, Inc. completed an additional closing under its Securities Purchase Agreement with Ascent Partners Fund LLC, issuing a Senior Secured Convertible Promissory Note with an aggregate principal amount of $329,670.33 for a purchase price of $300,000. The note bears 7% annual interest payable monthly and matures on September 1, 2027, or upon the Option Closing Date. It is convertible at $4.28 per share with a floor price of $1.07 and includes mandatory prepayment terms for subsequent offerings. Profusa, Inc. operates in the biotechnology industry, focusing on photobiomodulation therapies.
